Nasdaq

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

CORAL GABLES, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), today reported financial results for the first quarter of 2025 and ...

Joby Aviation: Hold For Now, But Ready To Buy The Commercial Launch Catalyst

Joby Aviation is positioned as a leading eVTOL manufacturer, pursuing vertical integration and in-house production to build a ...
Seeking Alpha

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

CORAL GABLES, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals (CPRX), Inc. today reported financial results for the fourth quarter and full year 2024 and provided a business update.
Nasdaq

Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update

Achieved Record Q2 2025 Total Revenues of $146.6 Million, an Increase of 19.4% YoY, Marking Another Quarter of Consecutive Growth Reported Record First Half 2025 Total Revenues of $288.0 Million, an ...